World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
77
Citations
23993
World Ranking
18366
National Ranking
9166

Homer A. Macapinlac publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Homer A. Macapinlac sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 325 publications — 22nd percentile

22% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Homer A. Macapinlac D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Homer A. Macapinlac sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 77 D-Index — 10th percentile

10% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Homer A. Macapinlac is affiliated with The University of Texas MD Anderson Cancer Center in the United States. Their research primarily spans the field of Medicine, with a strong focus on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine, Oncology, Pathology and Forensic Medicine, and Immunology. The scientist's investigations cover various specialized topics within medical research.

Their main research interests and topics include:

  • Medical Imaging Techniques and Applications
  • Prostate Cancer Treatment and Research
  • Radiopharmaceutical Chemistry and Applications
  • CAR-T cell therapy research
  • Prostate Cancer Diagnosis and Treatment
  • Lymphoma Diagnosis and Treatment
  • Cancer, Hypoxia, and Metabolism

Macapinlac has contributed to numerous scientific publications. Some recent papers include:

  • Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors, 2020, New England Journal of Medicine
  • Safety, efficacy and determinants of response of allogeneic CD19-specific CAR-NK cells in CD19+ B cell tumors: a phase 1/2 trial, 2024, Nature Medicine
  • Perfusion SPECT/CT to diagnose pulmonary embolism during COVID-19 pandemic, 2020, European Journal of Nuclear Medicine and Molecular Imaging
  • Monoclonal antibody based radiopharmaceuticals for imaging and therapy, 2021, Current Problems in Cancer
  • Phase I Study of P-cadherin-targeted Radioimmunotherapy with 90Y-FF-21101 Monoclonal Antibody in Solid Tumors, 2020, Clinical Cancer Research

Frequent publication venues include:

  • Diagnostics (5 publications)
  • European Journal of Nuclear Medicine and Molecular Imaging (3 publications)
  • Clinical Nuclear Medicine (3 publications)
  • Current Problems in Cancer (2 publications)
  • Nuclear Medicine Communications (2 publications)

Collaboration has been a notable aspect of Macapinlac's work, with several frequently co-authored researchers, such as:

  • Kalevi Kairemo (10 joint publications)
  • Vivek Subbiah (7 joint publications)
  • Yang Lü (6 joint publications)
  • Ajalaya Teyateeti (6 joint publications)
  • Gregory Ravizzini (4 joint publications)

Best Publications

  • Correlation of Computed Tomography and Positron Emission Tomography in Patients With Metastatic Gastrointestinal Stromal Tumor Treated at a Single Institution With Imatinib Mesylate: Proposal of New Computed Tomography Response Criteria

    Haesun Choi;Chuslip Charnsangavej;Silvana C. Faria;Homer A. Macapinlac

  • Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors

    Enli Liu;David Marin;Pinaki Banerjee;Homer A. Macapinlac

  • Tumor Treatment Response Based on Visual and Quantitative Changes in Global Tumor Glycolysis Using PET-FDG Imaging. The Visual Response Score and the Change in Total Lesion Glycolysis.

    Steven M. Larson;Yusuf Erdi;Timothy Akhurst;Madhu Mazumdar

  • We Should Desist Using RECIST, at Least in GIST

    Robert S. Benjamin;Haesun Choi;Homer A. Macapinlac;Michael A. Burgess

  • CT evaluation of the response of gastrointestinal stromal tumors after imatinib mesylate treatment: a quantitative analysis correlated with FDG PET findings.

    Haesun Choi;Chuslip Charnsangavej;Silvana De Castro Faria;Eric P. Tamm

  • Effect of Respiratory Gating on Quantifying PET Images of Lung Cancer

    Sadek A. Nehmeh;Yusuf E. Erdi;Clifton C. Ling;Kenneth E. Rosenzweig

  • Radiotherapy treatment planning for patients with non-small cell lung cancer using positron emission tomography (PET).

    Yusuf E. Erdi;Kenneth Rosenzweig;Alev K. Erdi;Homer A. Macapinlac

  • [18F]-2-Fluoro-2-Deoxy-d-Glucose Positron Emission Tomography Localizes Residual Thyroid Cancer in Patients with Negative Diagnostic 131I Whole Body Scans and Elevated Serum Thyroglobulin Levels

    Weiping Wang;Homer Macapinlac;Steven M. Larson;Samuel D.J. Yeh

  • Inflammatory breast cancer: PET/CT, MRI, mammography, and sonography findings

    Wei Tse Yang;Huong Le-Petross;Homer A Macapinlac;Selin Carkaci

  • A Missense Mutation in KIT Kinase Domain 1 Correlates with Imatinib Resistance in Gastrointestinal Stromal Tumors

    Lei L. Chen;Jonathan C. Trent;Elsie F. Wu;Gregory N. Fuller

  • Prognostic value of [18F]fluorodeoxyglucose positron emission tomographic scanning in patients with thyroid cancer.

    Weiping Wang;Steven M. Larson;Melissa Fazzari;Satish K. Tickoo

  • [18F] fluorodeoxyglucose uptake by positron emission tomography predicts outcome of non-small-cell lung cancer

    Ryohei Sasaki;Ritsuko Komaki;Homer Macapinlac;Jeremy Erasmus

  • Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer

    Stephen G. Swisher;Mary Maish;Jeremy J. Erasmus;Arlene M. Correa

  • The Role of 18F-FDG PET in Staging and Early Prediction of Response to Therapy of Recurrent Gastrointestinal Stromal Tumors

    Isis Gayed;Thuan Vu;Revathy Iyer;Marcella Johnson

  • 2-Fluoro-2-deoxy-D-glucose positron emission tomography imaging is predictive of pathologic response and survival after preoperative chemoradiation in patients with esophageal carcinoma.

    Stephen G. Swisher;Jeremy Erasmus;Mary Maish;Arlene M. Correa

  • Results of the American College of Surgeons Oncology Group Z0050 trial: the utility of positron emission tomography in staging potentially operable non–small cell lung cancer

    Carolyn E Reed;David H Harpole;Katherine E Posther;Sandra L Woolson

  • Utility of 18F-FDG positron emission tomography scanning on selection of patients for resection of hepatic colorectal metastases

    Yuman Fong;Pierre F Saldinger;Timothy Akhurst;Homer Macapinlac

  • Attenuation Correction of PET Images with Respiration-Averaged CT Images in PET/CT

    Tinsu Pan;Osama Mawlawi;Sadek A. Nehmeh;Yusuf E. Erdi

  • Bone Metastases in Patients with Metastatic Breast Cancer: Morphologic and Metabolic Monitoring of Response to Systemic Therapy with Integrated PET/CT

    Ukihide Tateishi;Cristina Gamez;Shaheenah Dawood;Henry W D Yeung

  • Fluorinated deoxyglucose positron emission tomography imaging in progressive metastatic prostate cancer

    Michael J Morris;Timothy Akhurst;Timothy Akhurst;Iman Osman;Rodolfo Nunez

Frequent Co-Authors

Steven M. Larson
Steven M. Larson Memorial Sloan Kettering Cancer Center
Andrew M. Scott
Andrew M. Scott La Trobe University
Jaffer A. Ajani
Jaffer A. Ajani The University of Texas MD Anderson Cancer Center
Wayne L. Hofstetter
Wayne L. Hofstetter The University of Texas MD Anderson Cancer Center
Stephen G. Swisher
Stephen G. Swisher The University of Texas MD Anderson Cancer Center
Stanley J. Goldsmith
Stanley J. Goldsmith Cornell University
John L. Humm
John L. Humm Memorial Sloan Kettering Cancer Center
Massimo Cristofanilli
Massimo Cristofanilli Cornell University
Luis Fayad
Luis Fayad The University of Texas MD Anderson Cancer Center
Robert S. Benjamin
Robert S. Benjamin The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring careers in medicine doesn’t always mean attending medical school. Today, there are many high-demand healthcare pathways you can pursue online. Programs such as HIM programs prepare students to handle vital health information, supporting hospitals and clinics with secure data management.

Another fast-growing field is medical billing and coding. Completing billing and coding classes online is a flexible, affordable way to launch a pivotal healthcare career — often in less time than traditional degrees.

For those interested in direct patient care, cheap online FNP programs allow you to advance your nursing expertise and qualify as a Family Nurse Practitioner, right from home. Entry-level nurses can also take advantage of cheap online nursing programs to start their careers quickly and at lower cost.

These flexible online degrees offer diverse roles in healthcare and can serve as stepping stones to more advanced positions or specialized areas over time.

Best Scientists Citing Homer A. Macapinlac

Trending Scientists

Recently Published Articles